Clinical feasibility of remote intermittently scanned continuous glucose monitoring in coronavirus disease 2019 patients with and without diabetes during dexamethasone therapy

In conclusion, although isCGM may not be as accurate as traditional blood glucose monitoring, it has good reliability in COVID-19 patients with and without diabetes during dexamethasone therapy.PMID:34937812 | DOI:10.1507/endocrj.EJ21-0540

Source: Endocrine Journal - December 23, 2021 Category: Endocrinology Authors: Naoya Shimizu Akinori Hayashi Shiori Ito Agena Suzuki Rei Fujishima Kenta Matoba Tatsuhiko Wada Koji Takano Masato Katagiri Masayoshi Shichiri Source Type: research